BioMarin Pharmaceutical Price to Free Cash Flow Ratio 2010-2024 | BMRN
- BioMarin Pharmaceutical average price to free cash flow ratio for 2023 was 73.81, a 55% decline from 2022.
- BioMarin Pharmaceutical average price to free cash flow ratio for 2022 was 164.01, a 42.97% decline from 2021.
- BioMarin Pharmaceutical average price to free cash flow ratio for 2021 was 114.72, a 18.81% increase from 2020.
Price to free cash flow ratio can be defined as